Position in EXEL
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$240,852,392
+$56,442,678 QoQ
Shares Held
4,426,620
+3.0% QoQ
Ownership
1.79%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#14
of 739 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 88%
Shared 7%
None 5%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,102,677,105 across 230 Biotechnology names. EXEL ranks #5 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
This page
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in EXEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $240,852,392 | 4,426,620 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $184,409,714 | 4,299,597 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $186,701,642 | 4,259,677 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $172,671,664 | 4,180,912 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $165,798,808 | 3,761,316 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $156,370,044 | 4,235,375 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $169,810,218 | 5,099,406 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $136,314,673 | 5,252,974 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $115,432,904 | 5,137,201 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $113,604,145 | 4,787,364 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $109,406,800 | 4,560,517 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $100,366,683 | 4,593,441 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $90,116,871 | 4,715,692 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $90,311,467 | 4,652,832 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $70,132,138 | 4,372,328 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $63,275,837 | 4,035,449 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $78,690,499 | 3,779,563 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $84,580,160 | 3,730,929 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $61,858,569 | 3,383,948 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $59,188,533 | 2,799,836 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $38,774,528 | 2,128,130 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $48,066,934 | 2,127,797 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $43,280,593 | 2,156,482 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $53,572,199 | 2,191,092 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $52,031,693 | 2,191,731 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $37,517,231 | 2,178,701 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||